FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13
Frequently Asked Questions
What is Market Cap of FibroBiologics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. FibroBiologics Inc market cap is $24.06M.
What is the 52-week high for FibroBiologics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. FibroBiologics Inc 52 week high is $4.41 as of September 08, 2025.
What is the 52-week low for FibroBiologics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. FibroBiologics Inc 52 week low is $0.5282 as of September 08, 2025.
What is FibroBiologics Inc stock price today?
FibroBiologics Inc stock price today is $0.5743.
What was FibroBiologics Inc stock price yesterday?
FibroBiologics Inc stock price yesterday was $0.5939.
What is the PE ratio of FibroBiologics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. FibroBiologics Inc’s P/E ratio is -1.59.
What is the Price-to-Book ratio of FibroBiologics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. FibroBiologics Inc P/B ratio is 27.2827.
What is the 50-day moving average of FibroBiologics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. FibroBiologics Inc 50-day moving average is $0.6185.
